Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years-Reference-Cited by-同舟云学术

Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years

Published:2019-09-19 Issue:18 Volume:3 Page:2738-2747
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Borate Uma¹^ORCID,Norris Brianna A.¹,Statler Abby²^ORCID,Fu Rongwei³,Bucy Taylor¹,Sekeres Mikkael A.⁴

Affiliation:

1. Department of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR;

2. Department of Cancer Biostatistics, Cleveland Clinic, Cleveland, OH;

3. School of Public Health, Oregon Health and Science University, Portland, OR; and

4. Leukemia Program, Cleveland Clinic, Cleveland, OH

Abstract

Key PointsPatients with t-MDS are underrepresented in clinical trials when taking into account the prevalence of such patients. Eligibility criteria and sponsorship type may contribute to t-MDS patient exclusion.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/3/18/2738/1223280/advancesadv2019000293.pdf

Reference52 articles.

1. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs;Rollison;Blood,2008

2. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations;West;Ann N Y Acad Sci,2014

3. Epidemiology of myelodysplastic syndromes;Ma;Am J Med,2012

4. Therapy-related myelodysplastic syndromes, or are they?;Abou Zahr;Blood Rev,2017

5. Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease;Visconte;Blood Res,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy-related myelodysplastic syndromes in the genomics era;Bulletin du Cancer;2023-11

2. DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28

3. Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT;Bone Marrow Transplantation;2022-04-22

4. Comparison of Physician-recorded Toxicities and Patient-reported Outcomes of Five Different Radiotherapy Methods for Prostate Cancer;Anticancer Research;2021-05

5. Comorbidities and malignancies negatively affect survival in myelodysplastic syndromes: a population-based study;Blood Advances;2021-03-03